Indications
Therapeutic Asset Ratings
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Adriamycin
Waldenstrom Macroglobulinemia
BeOne Medicines
P2
BB
(69)
asc30
Obesity Disorder
Ascletis Pharma (China) Co., Limited
P2
BB
(69)
Azacitidine
Acute Myeloid Leukemia With Abnormal Bone Marrow Eosinophils Inv(16)(P13q22) Or T(16;16)(P13;Q22)
The First Affiliated Hospital of Soochow University
P2
BB
(69)
Berzosertib
Small Cell Lung Carcinoma
National Cancer Institute (NCI)
P2
BB
(69)
Cediranib
Anaplastic Astrocytoma
National Cancer Institute (NCI)
P2
BB
(69)
Cediranib
Anaplastic Oligodendroglioma
National Cancer Institute (NCI)
P2
BB
(69)
Cediranib
Giant Cell Glioblastoma
Lawrence Recht
P2
BB
(69)
Cediranib
Adult Glioblastoma
Lawrence Recht
P2
BB
(69)
Cediranib
Mixed Glioma
National Cancer Institute (NCI)
P2
BB
(69)
Cediranib
Non-Small Cell Lung Carcinoma
Wake Forest University Health Sciences
P2
BB
(69)
Cediranib
Metastatic Melanoma
M.D. Anderson Cancer Center
P2
BB
(69)
Cyclophosphamide
Intraocular Lymphoma
Peking Union Medical College Hospital
P2
BB
(69)
Cyclophosphamide
Nodal Marginal Zone B-Cell Lymphoma
SWOG Cancer Research Network
P2
BB
(69)
Cyclophosphamide
Peritoneum Cancer
Peking University
P2
BB
(69)
Cyclophosphamide
Post-Transplant Lymphoproliferative Disease
Washington University School of Medicine
P2
BB
(69)
Darolutamide
Breast Cancer
Vandana Abramson
P2
BB
(69)
Dexasone
Angioimmunoblastic T-Cell Lymphoma
Ou Bai, MD/PHD
P2
BB
(69)
Etoposide
HIV Infectious Disease
AIDS Malignancy Consortium
P2
BB
(69)
Fludarabine
Leukemia, Myeloid, Accelerated-Phase
University of Illinois at Chicago
P2
BB
(69)
Fludarabine
Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
Ohio State University Comprehensive Cancer Center
P2
BB
(69)
Fludarabine
Burkitt Lymphoma
City of Hope Medical Center
P2
BB
(69)
Irinotecan
Adenocarcinoma
University of Chicago
P2
BB
(69)
Irinotecan
Follicular Lymphoma
University of Michigan Rogel Cancer Center
P2
BB
(69)
Irinotecan
Mantle Cell Lymphoma
University of Michigan Rogel Cancer Center
P2
BB
(69)
Mitoxantrone
Acute Myeloid Leukemia With T(8;21)(Q22;Q22) Translocation
BGI, China
P2
BB
(69)
Showing 1276 to 1300 of 42,301 assets
Previous
Page 52 of 1693
Next